Chimeric Antigen Receptor (CAR) T cell therapy is a pivotal treatment for hematological malignancies. However, CAR T cell products exhibit batch-to-batch variability in cell number, quality, and in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results